AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivo

Axonal damage is an early step in traumatic and neurodegenerative disorders of the central nervous system (CNS). Damaged axons are not able to regenerate sufficiently in the adult mammalian CNS, leading to permanent neurological deficits. Recently, we showed that inhibition of the autophagic protein...

Full description

Bibliographic Details
Main Authors: Ribas, VT, Vahsen, BF, Tatenhorst, L, Estrada, V, Dambeck, V, Almeida, RA, Bähr, M, Michel, U, Koch, JC, Müller, HW, Lingor, P
Format: Journal article
Language:English
Published: Springer Nature 2021
_version_ 1797111156624588800
author Ribas, VT
Vahsen, BF
Tatenhorst, L
Estrada, V
Dambeck, V
Almeida, RA
Bähr, M
Michel, U
Koch, JC
Müller, HW
Lingor, P
author_facet Ribas, VT
Vahsen, BF
Tatenhorst, L
Estrada, V
Dambeck, V
Almeida, RA
Bähr, M
Michel, U
Koch, JC
Müller, HW
Lingor, P
author_sort Ribas, VT
collection OXFORD
description Axonal damage is an early step in traumatic and neurodegenerative disorders of the central nervous system (CNS). Damaged axons are not able to regenerate sufficiently in the adult mammalian CNS, leading to permanent neurological deficits. Recently, we showed that inhibition of the autophagic protein ULK1 promotes neuroprotection in different models of neurodegeneration. Moreover, we demonstrated previously that axonal protection improves regeneration of lesioned axons. However, whether axonal protection mediated by ULK1 inhibition could also improve axonal regeneration is unknown. Here, we used an adeno-associated viral (AAV) vector to express a dominant-negative form of ULK1 (AAV.ULK1.DN) and investigated its effects on axonal regeneration in the CNS. We show that AAV.ULK1.DN fosters axonal regeneration and enhances neurite outgrowth in vitro. In addition, AAV.ULK1.DN increases neuronal survival and enhances axonal regeneration after optic nerve lesion, and promotes long-term axonal protection after spinal cord injury (SCI) in vivo. Interestingly, AAV.ULK1.DN also increases serotonergic and dopaminergic axon sprouting after SCI. Mechanistically, AAV.ULK1.DN leads to increased ERK1 activation and reduced expression of RhoA and ROCK2. Our findings outline ULK1 as a key regulator of axonal degeneration and regeneration, and define ULK1 as a promising target to promote neuroprotection and regeneration in the CNS.
first_indexed 2024-03-07T08:04:48Z
format Journal article
id oxford-uuid:37087988-cefe-4816-9715-2dd0438b0867
institution University of Oxford
language English
last_indexed 2024-03-07T08:04:48Z
publishDate 2021
publisher Springer Nature
record_format dspace
spelling oxford-uuid:37087988-cefe-4816-9715-2dd0438b08672023-10-27T07:21:26ZAAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivoJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:37087988-cefe-4816-9715-2dd0438b0867EnglishSymplectic ElementsSpringer Nature2021Ribas, VTVahsen, BFTatenhorst, LEstrada, VDambeck, VAlmeida, RABähr, MMichel, UKoch, JCMüller, HWLingor, PAxonal damage is an early step in traumatic and neurodegenerative disorders of the central nervous system (CNS). Damaged axons are not able to regenerate sufficiently in the adult mammalian CNS, leading to permanent neurological deficits. Recently, we showed that inhibition of the autophagic protein ULK1 promotes neuroprotection in different models of neurodegeneration. Moreover, we demonstrated previously that axonal protection improves regeneration of lesioned axons. However, whether axonal protection mediated by ULK1 inhibition could also improve axonal regeneration is unknown. Here, we used an adeno-associated viral (AAV) vector to express a dominant-negative form of ULK1 (AAV.ULK1.DN) and investigated its effects on axonal regeneration in the CNS. We show that AAV.ULK1.DN fosters axonal regeneration and enhances neurite outgrowth in vitro. In addition, AAV.ULK1.DN increases neuronal survival and enhances axonal regeneration after optic nerve lesion, and promotes long-term axonal protection after spinal cord injury (SCI) in vivo. Interestingly, AAV.ULK1.DN also increases serotonergic and dopaminergic axon sprouting after SCI. Mechanistically, AAV.ULK1.DN leads to increased ERK1 activation and reduced expression of RhoA and ROCK2. Our findings outline ULK1 as a key regulator of axonal degeneration and regeneration, and define ULK1 as a promising target to promote neuroprotection and regeneration in the CNS.
spellingShingle Ribas, VT
Vahsen, BF
Tatenhorst, L
Estrada, V
Dambeck, V
Almeida, RA
Bähr, M
Michel, U
Koch, JC
Müller, HW
Lingor, P
AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivo
title AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivo
title_full AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivo
title_fullStr AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivo
title_full_unstemmed AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivo
title_short AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivo
title_sort aav mediated inhibition of ulk1 promotes axonal regeneration in the central nervous system in vitro and in vivo
work_keys_str_mv AT ribasvt aavmediatedinhibitionofulk1promotesaxonalregenerationinthecentralnervoussysteminvitroandinvivo
AT vahsenbf aavmediatedinhibitionofulk1promotesaxonalregenerationinthecentralnervoussysteminvitroandinvivo
AT tatenhorstl aavmediatedinhibitionofulk1promotesaxonalregenerationinthecentralnervoussysteminvitroandinvivo
AT estradav aavmediatedinhibitionofulk1promotesaxonalregenerationinthecentralnervoussysteminvitroandinvivo
AT dambeckv aavmediatedinhibitionofulk1promotesaxonalregenerationinthecentralnervoussysteminvitroandinvivo
AT almeidara aavmediatedinhibitionofulk1promotesaxonalregenerationinthecentralnervoussysteminvitroandinvivo
AT bahrm aavmediatedinhibitionofulk1promotesaxonalregenerationinthecentralnervoussysteminvitroandinvivo
AT michelu aavmediatedinhibitionofulk1promotesaxonalregenerationinthecentralnervoussysteminvitroandinvivo
AT kochjc aavmediatedinhibitionofulk1promotesaxonalregenerationinthecentralnervoussysteminvitroandinvivo
AT mullerhw aavmediatedinhibitionofulk1promotesaxonalregenerationinthecentralnervoussysteminvitroandinvivo
AT lingorp aavmediatedinhibitionofulk1promotesaxonalregenerationinthecentralnervoussysteminvitroandinvivo